Work

Phase I study of BTK inhibitor ibrutinib with temozolomide and radiation in newly-diagnosed glioblastoma (EQUILIBRIUM): Final trial report.

Year: 2023

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2023.41.16_suppl.2067

Authors: Manmeet Singh Ahluwalia, Ahmad Ozair, Atulya Aman Khosla, Neha Patel, Paul Elson, Erin Sennett Murphy, Jennifer S. Yu, Samuel T. Chao, John H. Suh, Glen Stevens, David M. Peereboom

Institutions: Baptist Hospital of Miami, Baptist Health South Florida, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4379283542

Cites:

Cited by: 3

Related to: 10